TABLE 15-3
A chemist employed by a pharmaceutical firm has developed a muscle relaxant. She took a sample of 14 people suffering from extreme muscle constriction. She gave each a vial containing a dose (X) of the drug and recorded the time to relief (Y) measured in seconds for each. She fit a "centered" curvilinear model to this data. The results obtained by Microsoft Excel follow, where the dose (X) given has been "centered."

-Referring to Table 15-3, suppose the chemist decides to use an F test to determine if there is a significant curvilinear relationship between time and dose. If she chooses to use a level of significance of 0.01 she would decide that there is a significant curvilinear relationship.

Question

TABLE 15-3
A chemist employed by a pharmaceutical firm has developed a muscle relaxant. She took a sample of 14 people suffering from extreme muscle constriction. She gave each a vial containing a dose (X) of the drug and recorded the time to relief (Y) measured in seconds for each. She fit a "centered" curvilinear model to this data. The results obtained by Microsoft Excel follow, where the dose (X) given has been "centered."
 
-Referring to Table 15-3, suppose the chemist decides to use an F test to determine if there is a significant curvilinear relationship between time and dose. If she chooses to use a level of significance of 0.01 she would decide that there is a significant curvilinear relationship.

Quizplus · Accepted Answer

The decision to determine if there is a significant curvilinear relationship using an F test at a 0.01 significance level depends on the calculated F statistic and the critical F value from the F distribution table. Without these specific values, we cannot conclude whether the relationship is significant.

TABLE 15-3 a Chemist Employed by a Pharmaceutical Firm Has Developed a Developed